Use of a Mobile-based App for SCD Patients
| Status: | Recruiting |
|---|---|
| Conditions: | Chronic Pain, Chronic Pain, Anemia |
| Therapuetic Areas: | Hematology, Musculoskeletal |
| Healthy: | No |
| Age Range: | 12 - 100 |
| Updated: | 11/10/2018 |
| Start Date: | January 2015 |
| End Date: | December 2019 |
| Contact: | Christle cameron, LPN |
| Email: | christle.cameron@dm.duke.edu |
| Phone: | 9196846464 |
Use of a Mobile-based Pain Assessment Application for SCD Patients
The study will seek to enroll 100 sickle cell or thalassemia patients who are age 12 or older
who have access to a smartphone or tablet with Internet access daily.
The study will evaluate patient-reported comfort level with using a mobile device to record
their pain levels, as well as adherence to recording these levels daily.
The study will track patients' assessment of their pain, actions taken, and outcomes related
to pain management and provider involvement.
This study will attempt to collect information about differences in the use of two
traditional pain assessment modes (verbal scale and paper) versus the use of a pain
assessment tool on a mobile device in the form of a smartphone, tablet, or iPad with an
Android or iOS operating system.
who have access to a smartphone or tablet with Internet access daily.
The study will evaluate patient-reported comfort level with using a mobile device to record
their pain levels, as well as adherence to recording these levels daily.
The study will track patients' assessment of their pain, actions taken, and outcomes related
to pain management and provider involvement.
This study will attempt to collect information about differences in the use of two
traditional pain assessment modes (verbal scale and paper) versus the use of a pain
assessment tool on a mobile device in the form of a smartphone, tablet, or iPad with an
Android or iOS operating system.
The study will evaluate patient-reported comfort level with using a mobile device to record
their pain levels, as well as adherence to recording these levels daily. The study will track
patients' assessment of their pain, actions taken, and outcomes related to pain management
and provider involvement. This study will attempt to collect information about differences in
the use of two traditional pain assessment modes (verbal scale and paper) versus the use of a
pain assessment tool on a mobile device in the form of a smartphone, tablet, or iPad with an
Android or iOS operating system. The study will seek to enroll 100 sickle cell or thalassemia
patients who are age 12 or older who have access to a smartphone or tablet with Internet
access daily. Patients enrolled in this study will be ask to use a mobile device such as a
smartphone or a tablet with Android or iOS operating system to record daily pain level and
related information once daily or more frequently for a period of forty-two days. A 1:1
randomization assignment will be made to have patients receive automated "canned" provider
feedback or not.
their pain levels, as well as adherence to recording these levels daily. The study will track
patients' assessment of their pain, actions taken, and outcomes related to pain management
and provider involvement. This study will attempt to collect information about differences in
the use of two traditional pain assessment modes (verbal scale and paper) versus the use of a
pain assessment tool on a mobile device in the form of a smartphone, tablet, or iPad with an
Android or iOS operating system. The study will seek to enroll 100 sickle cell or thalassemia
patients who are age 12 or older who have access to a smartphone or tablet with Internet
access daily. Patients enrolled in this study will be ask to use a mobile device such as a
smartphone or a tablet with Android or iOS operating system to record daily pain level and
related information once daily or more frequently for a period of forty-two days. A 1:1
randomization assignment will be made to have patients receive automated "canned" provider
feedback or not.
Inclusion Criteria:
- SCD, thalassemia, or history of experiencing pain
Exclusion Criteria:
We found this trial at
1
site
2301 Erwin Rd
Durham, North Carolina 27710
Durham, North Carolina 27710
919-684-8111
Principal Investigator: Jude Jonassaint, RN
Phone: 919-668-6035
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials
